IL136742A0 - Kappa receptor opioid peptides - Google Patents

Kappa receptor opioid peptides

Info

Publication number
IL136742A0
IL136742A0 IL13674298A IL13674298A IL136742A0 IL 136742 A0 IL136742 A0 IL 136742A0 IL 13674298 A IL13674298 A IL 13674298A IL 13674298 A IL13674298 A IL 13674298A IL 136742 A0 IL136742 A0 IL 136742A0
Authority
IL
Israel
Prior art keywords
opioid peptides
kappa receptor
receptor opioid
kappa
peptides
Prior art date
Application number
IL13674298A
Other languages
English (en)
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Bv filed Critical Ferring Bv
Publication of IL136742A0 publication Critical patent/IL136742A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1027Tetrapeptides containing heteroatoms different from O, S, or N
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/10Drugs for disorders of the urinary system of the bladder
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1002Tetrapeptides with the first amino acid being neutral
    • C07K5/1016Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1024Tetrapeptides with the first amino acid being heterocyclic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nutrition Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL13674298A 1997-12-23 1998-12-22 Kappa receptor opioid peptides IL136742A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/997,208 US5965701A (en) 1997-12-23 1997-12-23 Kappa receptor opioid peptides
PCT/US1998/027282 WO1999032510A1 (en) 1997-12-23 1998-12-22 Kappa receptor opioid peptides

Publications (1)

Publication Number Publication Date
IL136742A0 true IL136742A0 (en) 2001-06-14

Family

ID=25543752

Family Applications (3)

Application Number Title Priority Date Filing Date
IL13674298A IL136742A0 (en) 1997-12-23 1998-12-22 Kappa receptor opioid peptides
IL136742A IL136742A (en) 1997-12-23 2000-06-12 Opaque peptides for kafa receptor and preparations containing them
IL178471A IL178471A0 (en) 1997-12-23 2006-10-05 Kappa receptor opioid peptides and compositions comprising them

Family Applications After (2)

Application Number Title Priority Date Filing Date
IL136742A IL136742A (en) 1997-12-23 2000-06-12 Opaque peptides for kafa receptor and preparations containing them
IL178471A IL178471A0 (en) 1997-12-23 2006-10-05 Kappa receptor opioid peptides and compositions comprising them

Country Status (32)

Country Link
US (1) US5965701A (de)
EP (1) EP1042359B1 (de)
JP (1) JP4275852B2 (de)
KR (1) KR100629548B1 (de)
CN (1) CN1154655C (de)
AR (1) AR014167A1 (de)
AT (1) ATE301670T1 (de)
AU (1) AU747806B2 (de)
BR (2) BR9814499B1 (de)
CA (1) CA2315878C (de)
CR (1) CR5936A (de)
CZ (1) CZ297281B6 (de)
DE (1) DE69831176T2 (de)
DK (1) DK1042359T3 (de)
EE (1) EE04440B1 (de)
ES (1) ES2247735T3 (de)
HR (1) HRP20000415B1 (de)
HU (1) HU227640B1 (de)
IL (3) IL136742A0 (de)
MY (1) MY117542A (de)
NO (1) NO327080B1 (de)
NZ (1) NZ505183A (de)
PL (1) PL195842B1 (de)
PT (1) PT1042359E (de)
RU (1) RU2217437C2 (de)
SK (1) SK286135B6 (de)
TR (1) TR200001985T2 (de)
TW (1) TW580502B (de)
UA (1) UA68366C2 (de)
UY (1) UY25327A1 (de)
WO (1) WO1999032510A1 (de)
ZA (1) ZA9811801B (de)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9006175B2 (en) 1999-06-29 2015-04-14 Mannkind Corporation Potentiation of glucose elimination
WO2001036006A1 (en) * 1999-11-19 2001-05-25 Palatin Technologies, Inc. Opioid metallopeptide compositions and methods
DE10116978A1 (de) * 2001-04-05 2002-10-10 Merck Patent Gmbh Kappa-Opiatagonisten für die Behandlung von Erkrankungen der Blase
WO2002089845A1 (fr) * 2001-05-08 2002-11-14 Toray Industries, Inc. Remedes contre la sepsie
US6923175B2 (en) 2002-03-20 2005-08-02 Mannkind Corporation Inhalation apparatus
ATE486064T1 (de) 2004-08-20 2010-11-15 Mannkind Corp Katalyse der diketopiperazinsynthese
KR20130066695A (ko) 2004-08-23 2013-06-20 맨카인드 코포레이션 약물 전달용 디케토피페라진염, 디케토모르포린염 또는 디케토디옥산염
MX373000B (es) 2005-09-14 2020-05-21 Mannkind Corp Metodo para formulacion de farmaco basado en el aumento de la afinidad de agentes activos hacia las superficies de microparticulas cristalinas.
EP1986679B1 (de) 2006-02-22 2017-10-25 MannKind Corporation Verfahren zur verbesserung der pharmazeutischen eigenschaften von mikropartikeln mit diketopiperazin und einem wirkstoff
CA2653072A1 (en) * 2006-05-26 2007-12-06 Cara Therapeutics, Inc. Method for elevating prolactin in mammals
CN101454338A (zh) * 2006-05-26 2009-06-10 卡拉治疗学股份有限公司 κ阿片样受体肽的N-氧化物
US7713937B2 (en) * 2006-11-10 2010-05-11 Cara Therapeutics, Inc. Synthetic peptide amides and dimeric forms thereof
MX2009005000A (es) 2006-11-10 2009-10-12 Cara Therapeutics Inc Amidas de peptidos sinteticos.
US7842662B2 (en) * 2006-11-10 2010-11-30 Cara Therapeutics, Inc. Synthetic peptide amide dimers
US8906859B2 (en) * 2006-11-10 2014-12-09 Cera Therapeutics, Inc. Uses of kappa opioid synthetic peptide amides
US8236766B2 (en) * 2006-11-10 2012-08-07 Cara Therapeutics, Inc. Uses of synthetic peptide amides
WO2008077194A1 (en) * 2006-12-22 2008-07-03 Xenome Ltd Receptor agonists
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
CN101827626B (zh) 2008-06-13 2015-03-18 曼金德公司 干粉吸入器和用于药物输送的系统
ES2421385T3 (es) 2008-06-20 2013-09-02 Mannkind Corp Aparato interactivo y procedimiento para establecer el perfil, en tiempo real, de esfuerzos de inhalación
TWI532497B (zh) 2008-08-11 2016-05-11 曼凱公司 超快起作用胰島素之用途
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
DK2405963T3 (da) 2009-03-11 2013-12-16 Mannkind Corp Apparat, system og fremgangsmåde til at måle modstand i en inhalator
KR102584844B1 (ko) 2009-06-12 2023-10-04 맨카인드 코포레이션 한정된 비표면적을 갖는 디케토피페라진 마이크로입자
CA2778698A1 (en) 2009-11-03 2011-05-12 Mannkind Corporation An apparatus and method for simulating inhalation efforts
CN102985125A (zh) 2010-06-21 2013-03-20 曼金德公司 干粉药物输送系统和方法
SG194034A1 (en) 2011-04-01 2013-11-29 Mannkind Corp Blister package for pharmaceutical cartridges
WO2012174472A1 (en) 2011-06-17 2012-12-20 Mannkind Corporation High capacity diketopiperazine microparticles
MX2014004983A (es) * 2011-10-24 2014-09-22 Mannkid Corp Metodos y composiciones para tratar dolor.
KR102264177B1 (ko) 2012-07-12 2021-06-11 맨카인드 코포레이션 건조 분말 약물 전달 시스템 및 방법
WO2014066856A1 (en) 2012-10-26 2014-05-01 Mannkind Corporation Inhalable influenza vaccine compositions and methods
EP3587404B1 (de) 2013-03-15 2022-07-13 MannKind Corporation Mikrokristalline diketopiperazinzusammensetzungen, verfahren zur herstellung und deren verwendung
MX375448B (es) 2013-07-18 2025-03-06 Mannkind Corp Composiciones farmacéuticas en polvo seco estables al calor y métodos.
EP3030294B1 (de) 2013-08-05 2020-10-07 MannKind Corporation Insufflationsvorrichtung
US10307464B2 (en) 2014-03-28 2019-06-04 Mannkind Corporation Use of ultrarapid acting insulin
CA2953653C (en) * 2014-06-26 2021-02-16 Maruishi Pharmaceutical Co., Ltd. Method for producing synthetic pentapeptide
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler
US10550150B2 (en) * 2015-05-11 2020-02-04 Cadila Healthcare Limited Short-chain peptides as Kappa (κ) opioid receptors (KOR) agonist
CN107098876B (zh) * 2016-02-23 2021-04-06 江苏恒瑞医药股份有限公司 苯基丙酰胺类衍生物、其制备方法及其在医药上的应用
US11084847B2 (en) 2016-09-27 2021-08-10 Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Polyamide compound and use thereof
EP3656782B1 (de) * 2017-07-21 2021-12-22 Sichuan Haisco Pharmaceutical Co., Ltd. Peptidamidverbindung und verfahren zu ihrer herstellung und ihre medizinische verwendung
CA3084201A1 (en) 2017-12-06 2019-06-13 Jiangsu Hengrul Medicine Co., Ltd. Salt of phenylpropionamide derivative and preparation method therefor
WO2019219019A1 (zh) 2018-05-16 2019-11-21 江苏恒瑞医药股份有限公司 一种kor受体激动剂药物组合物
CN114127086B (zh) * 2019-07-25 2023-10-20 四川海思科制药有限公司 氘代肽酰胺类化合物及其制备方法和在医药上的用途
CN114127085B (zh) * 2019-07-25 2024-08-13 西藏海思科制药有限公司 一种肽酰胺盐及其制备方法和在医药上的用途
US12215173B2 (en) 2019-08-07 2025-02-04 HUMANWELL PHARMACEUTICAL US, Inc. Kappa opioid receptor peptide amide ligands
KR20230024419A (ko) 2020-06-25 2023-02-20 휴먼웰 파마슈티컬 유에스 의학적 장애 치료용 펩티드
US20240336565A1 (en) 2021-07-02 2024-10-10 Acer Therapeutics, Inc. Solid forms of osanetant

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2013689B (en) * 1977-12-15 1982-03-24 Reckitt & Colmann Prod Ltd Compounds
GB8801304D0 (en) * 1988-01-21 1988-02-17 Ici Plc Diamine compounds
US5367053A (en) * 1993-05-19 1994-11-22 Houghten Pharmaceuticals, Inc. Opioid peptide inhibitors
RU2067000C1 (ru) * 1994-06-29 1996-09-27 Владислав Исакович Дейгин Пептид и способ его получения
US5610271A (en) * 1995-06-07 1997-03-11 Torrey Pines Institute For Molecular Studies Kappa receptor selective opioid peptides

Also Published As

Publication number Publication date
BRPI9814499B8 (pt) 2021-11-09
EE200000370A (et) 2001-10-15
EP1042359A1 (de) 2000-10-11
BRPI9814499A (pt) 2000-10-10
IL178471A0 (en) 2007-02-11
JP4275852B2 (ja) 2009-06-10
MY117542A (en) 2004-07-31
UY25327A1 (es) 2000-12-29
HUP0100626A3 (en) 2001-12-28
HUP0100626A2 (hu) 2001-08-28
KR100629548B1 (ko) 2006-09-27
PT1042359E (pt) 2005-11-30
BR9814499A (pt) 2000-10-10
CA2315878A1 (en) 1999-07-01
CZ297281B6 (cs) 2006-10-11
SK286135B6 (sk) 2008-04-07
TR200001985T2 (tr) 2000-11-21
DE69831176T2 (de) 2006-04-20
WO1999032510A1 (en) 1999-07-01
EE04440B1 (et) 2005-02-15
US5965701A (en) 1999-10-12
ES2247735T3 (es) 2006-03-01
PL195842B1 (pl) 2007-10-31
NO327080B1 (no) 2009-04-20
CA2315878C (en) 2010-11-16
RU2217437C2 (ru) 2003-11-27
HRP20000415B1 (en) 2004-06-30
KR20010033450A (ko) 2001-04-25
SK9602000A3 (en) 2001-01-18
ZA9811801B (en) 1999-06-22
TW580502B (en) 2004-03-21
BRPI9814499B1 (pt) 2014-10-21
DK1042359T3 (da) 2005-11-28
NZ505183A (en) 2001-09-28
ATE301670T1 (de) 2005-08-15
CN1154655C (zh) 2004-06-23
CR5936A (es) 2006-08-18
JP2001526295A (ja) 2001-12-18
AR014167A1 (es) 2001-02-07
CN1283201A (zh) 2001-02-07
AU1940299A (en) 1999-07-12
NO20003245D0 (no) 2000-06-21
WO1999032510A9 (en) 1999-09-23
DE69831176D1 (de) 2005-09-15
NO20003245L (no) 2000-08-23
PL341308A1 (en) 2001-04-09
BR9814499B1 (pt) 2014-10-21
UA68366C2 (en) 2004-08-16
HK1029349A1 (en) 2001-03-30
IL136742A (en) 2006-12-31
AU747806B2 (en) 2002-05-23
CZ20002382A3 (cs) 2000-12-13
EP1042359B1 (de) 2005-08-10
HU227640B1 (en) 2011-10-28
HRP20000415A2 (en) 2000-12-31

Similar Documents

Publication Publication Date Title
ZA9811801B (en) Kappa receptor opioid peptides
IL123258A0 (en) Opioid peptides
AU6868398A (en) Mu-opiate receptor peptides
PL344341A1 (en) Peptides
IL112903A0 (en) GnRH antagonist peptides
EP1007563A4 (de) Hm74a rezeptor
TW345977U (en) Improved structure for nozzle
GB9718110D0 (en) Peptides
HUP0003396A3 (en) Somatostatin antagonist peptides
ZA98256B (en) Tachykinin antagonists
GB9700154D0 (en) Peptides
GB9812675D0 (en) Peptides
IL114046A0 (en) New opioid peptide antagonists
SI1042359T1 (sl) Kappa receptorski opioidni peptidi
GB9827016D0 (en) Receptor protein
IL113441A0 (en) Opioid peptide analoog
GB9807890D0 (en) Peptides
ZA983615B (en) Kappa opioid agonists
GB9704857D0 (en) Accomodation
GB9701024D0 (en) Peptides
GB9713146D0 (en) Peptides
GB9706556D0 (en) Peptides
GB9717431D0 (en) Peptide synthesis
IL150203A0 (en) Non peptide tachykinin receptor antagonists
CA81622S (en) Seat cover dispenser

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed